The Science Behind the Headlines

Drug Discovery 301

Drug Discovery 301

DRUG DISCOVERY 301 The past two issues, the WEEKLY explored the first two stages of drug discovery. We looked at how pharmaceutical companies identify drug targets, or the molecules (usually proteins) involved in an illness that an ‘as yet undeveloped drug’ will...

read more

The free Biotech Primer WEEKLY explains the science behind today’s headlines. Delivered each Thursday directly to your inbox.

Subscribe to The WEEKLY today.

Drug Discovery 201

Drug Discovery 201

WE WANNA NEW DRUG “One that won’t make me sick/ One that won’t make me crash my car/ and make me feel three feet thick…” Huey Lewis is singing about love, but he voices very human concerns when it comes to the medicines that heal bodies and minds. Last week, the...

read more

Biotech for Non-Scientists

Drug Discovery 101

Drug Discovery 101

On the Road to New Medicines For most of the 20th century, we discovered new drugs by trial and error. Scientists investigated countless unrelated compounds in animals to see which improved disease symptoms. For instance, in the 1950s and 60s, British scientists at...

read more
An Egg-cellent Idea

An Egg-cellent Idea

An Egg-cellent Idea "The incredible, edible egg." This advertising slogan created for the American Egg Board in the 1970s rings truer than ever. Here’s why: scientists at the Roslin Institute (Midlothian, Scotland), part of the University of Edinburgh, recently...

read more

Medical Devices & Diagnostics

An Epigenetic Liquid Biopsy

An Epigenetic Liquid Biopsy

A New Type of Liquid Biopsy Biopsy. It can bring to mind painful cutting, punching and poking. Thankfully, these important and potentially life-saving procedures have moved into the new millennium along with the rest of us. Liquid biopsies have become a hot area of...

read more